Johnson & Johnson (JNJ) recalls infant cough products

More

Check your medicine cabinet for the following medicines for infants included in today's voluntary recall from Johnson & Johnson's (NYSE: JNJ) McNeil-PPC:
  • Concentrated Infants' Tylenol Drops plus Cold
  • Concentrated Infants' Tylenol Drops plus Cold & Cough
  • Pediacare Infant Drops Decongestant
  • Pediacare Infant Drops Decongestant & Cough
  • Pediacare Infant Dropper Decongestant
  • Pediacare Infant Dropper Long-acting Cough
  • Pediacare Infant Dropper Decongestant & Cough
According to its press release, the company has found "rare instances of misuse leading to overdose, particularly in infants under two years of age."

The recall does not include similar medicines for children two or older, or single-ingredient pain relievers and fever reducers for infants. The company has not yet divulged the scope or dollar value of this recall.

The company is cooperating with the Consumer Healthcare Products Association in a recommendation to the FDA to prominently label all such products in the future with the warning 'Do not use in children under two years of age."

The two brands included in the recall came to Johnson & Johnson in its purchase of Pfizer's (NYSE: PFE) Consumer Healthcare business late last year.

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA+150.2510,058.64
NASDAQ+24.822,150.87
S&P 500+13.781,070.52

Last updated: February 10, 2010: 06:27 AM

Hot Stocks

DailyFinance Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

WalletPop Headlines